Nature Communications (Oct 2018)

Incompatibility of the circadian protein BMAL1 and HNF4α in hepatocellular carcinoma

  • Baharan Fekry,
  • Aleix Ribas-Latre,
  • Corrine Baumgartner,
  • Jonathan R. Deans,
  • Christopher Kwok,
  • Pooja Patel,
  • Loning Fu,
  • Rebecca Berdeaux,
  • Kai Sun,
  • Mikhail G. Kolonin,
  • Sidney H. Wang,
  • Seung-Hee Yoo,
  • Frances M. Sladek,
  • Kristin Eckel-Mahan

DOI
https://doi.org/10.1038/s41467-018-06648-6
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 17

Abstract

Read online

Hepatocyte nuclear factor 4 alpha (HNF4α) is regulated by different promoters to generate two isoforms, one of which functions as a tumor suppressor. Here, the authors reveal that induction of the alternative isoform in hepatocellular carcinoma inhibits the circadian clock by repressing BMAL1, and the reintroduction of BMAL1 prevents HCC tumor growth.